Jerusalem Pharmaceuticals Co. Ltd. (PEX: JPH)

Jerusalem Pharmaceuticals Ratios and Metrics

Market cap in millions JOD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 25, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	46	49	42	36	35	36
Market Cap Growth	-9.19%	15.82%	16.13%	2.15%	-1.04%	-13.67%
Enterprise Value	42	41	39	37	39	39
Last Close Price	2.55	2.63	2.19	1.81	1.72	1.67
PE Ratio	12.44	9.57	7.72	6.97	11.75	7.93
PS Ratio	1.73	1.72	1.28	1.10	1.37	1.48
PB Ratio	1.01	0.99	0.91	0.74	0.81	0.92
P/FCF Ratio	14.19	8.72	3.62	13.20	111.66	62.38
P/OCF Ratio	9.65	7.44	3.47	8.42	26.14	21.21
EV/Sales Ratio	1.58	1.47	1.18	1.12	1.50	1.60
EV/EBITDA Ratio	6.93	5.73	5.19	5.20	9.16	7.96
EV/EBIT Ratio	8.42	6.49	6.20	6.48	13.58	10.53
EV/FCF Ratio	12.94	7.44	3.35	13.40	122.00	67.67
Debt / Equity Ratio	0.03	0.04	0.03	0.04	0.06	0.08
Debt / EBITDA Ratio	0.24	0.23	0.20	0.25	0.61	0.60
Debt / FCF Ratio	0.44	0.32	0.13	0.68	8.62	5.35
Asset Turnover	0.44	0.47	0.54	0.56	0.49	0.52
Inventory Turnover	1.78	1.70	1.79	1.61	1.40	1.34
Quick Ratio	2.51	3.14	2.88	2.80	2.49	1.97
Current Ratio	3.57	4.28	3.86	4.25	4.18	3.55
Return on Equity (ROE)	8.10%	10.45%	10.77%	9.55%	6.30%	9.66%
Return on Assets (ROA)	5.20%	6.60%	6.45%	6.06%	3.38%	4.94%
Return on Capital (ROIC)	6.47%	8.09%	7.94%	7.29%	4.03%	5.91%
Earnings Yield	8.04%	10.17%	12.15%	12.95%	7.47%	10.62%
FCF Yield	7.05%	11.46%	27.64%	7.58%	0.90%	1.60%
Dividend Yield	2.78%	2.70%	4.87%	4.70%	3.29%	4.24%
Payout Ratio	29.86%	36.63%	29.90%	20.25%	44.33%	32.24%
Total Shareholder Return	2.78%	2.70%	4.87%	4.70%	3.29%	4.24%

Source: S&P Capital IQ. Standard template. Financial Sources.